Treadmill Training and Quality of Life in Parkinson's Disease
NCT ID: NCT00890669
Last Updated: 2009-05-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
9 participants
INTERVENTIONAL
2007-08-31
2008-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Methods: Nine subjects with PD, Hoehn and Yahr stages 2 through 3, not demented and with capability to ambulate independently voluntarily participate in this study. The training program was divided into three phases (A1-B-A2): treadmill training with additional body load (A1), control condition (conventional physical therapy group) (B) and treadmill training with load again (A2). Each phase lasted six weeks. The quality of life and motor symptoms were assessed by PDQ-39 and UPDRS, respectively. Both evaluations and training were performed during on-phase of the medication cycle.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Resistance Training in Patients With Parkinson's Disease.
NCT02447146
Neuromodulation on Motor Function in Parkinson's Disease
NCT02250690
Amplitude and Rate of Intrinsic Feedback During Treadmill Training for Parkinson's Disease
NCT01987557
The Effect of Dual Tasking on Physical and Cognitive Functions in Patients With Parkinson Disease
NCT03902990
Efficacy of Pattern Respiratory PNF Associated Aerobic Training on Lung Volumes and 6MWT Test in Parkinson Individuals
NCT02600052
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
PD Group
Nine subjects with idiopathic PD, previously diagnosed by one specialist physician participated in this study.
Treadmill walking training with additional body load
The training program was divided into three phases (A1-B-A2):
* treadmill training with additional body load (A1),
* control condition (conventional physical therapy group) (B). and
* treadmill training with additional body load again (A2).
Each phase lasted six weeks, totaling 18 weeks. Both evaluations and training were performed during on-phase of the medication cycle.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Treadmill walking training with additional body load
The training program was divided into three phases (A1-B-A2):
* treadmill training with additional body load (A1),
* control condition (conventional physical therapy group) (B). and
* treadmill training with additional body load again (A2).
Each phase lasted six weeks, totaling 18 weeks. Both evaluations and training were performed during on-phase of the medication cycle.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Absence of dementia (Mini-Mental Status Examination - MMSE, defined according to educational level)
* Capacity to ambulate independently for at least 10 meters
Exclusion Criteria
* Use treadmill for at least six months prior to the study
* Other neurologic problems or musculoskeletal, cardiovascular and respiratory disease or uncorrected visual deficit that could represent risk and interfere in the accomplishment of the training
51 Years
81 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universidade Federal de Sao Carlos
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Universidade Federal de São Carlos
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nadiesca T Filippin, MSc
Role: PRINCIPAL_INVESTIGATOR
Universidade Federal de Sao Carlos
Rosana Mattioli, PhD
Role: STUDY_CHAIR
Universidade Federal de Sao Carlos
Paula H Lobo da Costa, PhD
Role: STUDY_DIRECTOR
Universidade Federal de Sao Carlos
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Universidade Federal de São Carlos
São Carlos, São Paulo, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CEP/UFSCar
Identifier Type: -
Identifier Source: secondary_id
234/07
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.